1,561 results match your criteria Seminars in Liver Disease [Journal]


Erratum: Novel Targets in the Immune Microenvironment of the Hepatic Sinusoids for Treating Liver Diseases.

Semin Liver Dis 2019 Apr 16. Epub 2019 Apr 16.

Centre for Liver Research, Institute of Immunology and Immunotherapy, Medical School, University of Birmingham, Edgbaston, Birmingham, United Kingdom.

View Article

Download full-text PDF

Source
http://www.thieme-connect.de/DOI/DOI?10.1055/s-0039-1688409
Publisher Site
http://dx.doi.org/10.1055/s-0039-1688409DOI Listing
April 2019
2 Reads

Direct-Acting Oral Anticoagulants (DOACs) in Cirrhosis and Cirrhosis-Associated Portal Vein Thrombosis.

Semin Liver Dis 2019 Apr 12. Epub 2019 Apr 12.

Division of Gastroenterology and Hepatology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.

Direct-acting oral anticoagulants (DOACs) have provided benefit in patients requiring anticoagulation for certain diseases by decreasing the burden of subcutaneous injections and the requirement for frequent monitoring through regular blood tests, to ensure adequacy of the therapeutic doses. Studies have demonstrated DOACs to be as safe, and in some instance safer, compared with traditional anticoagulants in the general population. However, the studies evaluating DOACs excluded patients with cirrhosis, a condition associated with an increased risk of developing portal vein thrombosis (PVT). Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1055/s-0039-1679934DOI Listing
April 2019
1 Read

Current Knowledge of Occult Hepatitis B Infection and Clinical Implications.

Semin Liver Dis 2019 Mar 25. Epub 2019 Mar 25.

Institute of Digestive Disease, The Chinese University of Hong Kong, Hong Kong SAR, People's Republic of China.

Occult hepatitis B infection (OBI) is a status of undetectable serum hepatitis B surface antigen (HBsAg) yet detectable serum and/or intrahepatic hepatitis B virus (HBV) DNA. Mutations in the preS1, preS2, and S regions of the gene may result in undetectable HBsAg. OBI may either result from a self-limiting acute hepatitis, or in patients with chronic hepatitis B who achieved HBsAg seroclearance, which refers to the loss of detectability of serum HBsAg with or without antibody to HBsAg (anti-HBs) in chronic hepatitis B (CHB) patients. Read More

View Article

Download full-text PDF

Source
http://www.thieme-connect.de/DOI/DOI?10.1055/s-0039-1678728
Publisher Site
http://dx.doi.org/10.1055/s-0039-1678728DOI Listing
March 2019
13 Reads

Genetics of Nonalcoholic Fatty Liver Disease: From Pathogenesis to Therapeutics.

Semin Liver Dis 2019 Mar 25. Epub 2019 Mar 25.

Institute of Medical Research A Lanari, School of Medicine, University of Buenos Aires, Ciudad Autonoma de Buenos Aires (C1427ARN), Argentina.

Here, the authors review the remarkable genetic discoveries that have illuminated the biology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH). The authors integrate genes associated with NAFLD and NASH into regulatory pathways to elucidate the disease pathogenesis. They review the evidence for molecular mediators of chronic liver damage, which suggests that convergent pathophenotypes, including inflammation and fibrosis, share common genetic modifiers. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1055/s-0039-1679920DOI Listing
March 2019
1 Read

Balloon Tamponade and Esophageal Stenting for Esophageal Variceal Bleeding in Cirrhosis: A Systematic Review and Meta-analysis.

Semin Liver Dis 2019 Mar 25. Epub 2019 Mar 25.

Swiss Liver Center, UVCM, Inselspital, Bern University Hospital, Department of Biomedical Research, University of Bern, Bern, Switzerland.

Failure to control variceal bleeding with current recommendations occurs in 10 to 20% of cases. This systematic review and meta-analysis analyzes the experience, results, and complications of "bridge" therapies for failure to control acute variceal bleeding: balloon tamponade and esophageal stents. The main outcomes assessed were failure to control bleeding and mortality in the short-term and medium-term follow-up, and adverse events. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1055/s-0039-1678726DOI Listing
March 2019
1 Read

Novel Targets in the Immune Microenvironment of the Hepatic Sinusoids for Treating Liver Diseases.

Semin Liver Dis 2019 Mar 25. Epub 2019 Mar 25.

Centre for Liver Research, Institute of Immunology and Immunotherapy, Medical School, University of Birmingham, Edgbaston, Birmingham, United Kingdom.

Immune dysregulation and accumulation of leukocytes is a hallmark of adult chronic liver diseases. Progressive hepatic inflammation can lead to fibrosis and cirrhosis with a high risk of liver failure or hepatocellular cancer (HCC). Recent advances have been made in the treatment of liver disease including the development of highly effective antiviral therapy for hepatitis C and the potential of immunotherapy for HCC. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1055/s-0039-1678727DOI Listing
March 2019
1 Read

Endoplasmic Reticulum Stress in Metabolic Liver Diseases and Hepatic Fibrosis.

Semin Liver Dis 2019 Mar 25. Epub 2019 Mar 25.

Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota.

Endoplasmic reticulum (ER) stress is a major contributor to liver disease and hepatic fibrosis, but the role it plays varies depending on the cause and progression of the disease. Furthermore, ER stress plays a distinct role in hepatocytes versus hepatic stellate cells (HSCs), which adds to the complexity of understanding ER stress and its downstream signaling through the unfolded protein response (UPR) in liver disease. Here, the authors focus on the current literature of ER stress in nonalcoholic and alcoholic fatty liver diseases, how ER stress impacts hepatocyte injury, and the role of ER stress in HSC activation and hepatic fibrosis. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1055/s-0039-1681032DOI Listing
March 2019
1 Read

Prevention of Hepatocellular Carcinoma by Statins: Clinical Evidence and Plausible Mechanisms.

Semin Liver Dis 2019 Mar 25. Epub 2019 Mar 25.

Department of Internal Medicine, Yonsei University College of Medicine, Yonsei University, Seoul, Republic of Korea.

Statins, or 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors, are widely used to treat hypercholesterolemia for primary and secondary prevention of cardiovascular disease. Statins inhibit HMG-CoA reductase, the rate-limiting step in cholesterol synthesis, and modulate the downstream signaling of the mevalonate pathway. In addition to the primary effect, the antitumor effect of statins can be associated with mevalonate pathway-mediated and nonmevalonate pathway-mediated mechanisms, which improve endothelial function and lead to proapoptotic, antiproliferative, antiinflammatory, and antifibrotic properties. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1055/s-0039-1679956DOI Listing
March 2019
1 Read

Liver Cancer Gene Discovery Using Gene Targeting, Sleeping Beauty, and CRISPR/Cas9.

Semin Liver Dis 2019 Mar 25. Epub 2019 Mar 25.

Division of Gastroenterology, Department of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.

Hepatocellular carcinoma (HCC) is a devastating and prevalent cancer with limited treatment options. Technological advances have enabled genetic screens to be employed in HCC model systems to characterize genes regulating tumor initiation and growth. Relative to traditional methods for studying cancer biology, such as candidate gene approaches or expression analysis, genetic screens have several advantages: they are unbiased, with no selection; can directly annotate gene function; and can uncover gene-gene interactions. Read More

View Article

Download full-text PDF

Source
http://www.thieme-connect.de/DOI/DOI?10.1055/s-0039-1678725
Publisher Site
http://dx.doi.org/10.1055/s-0039-1678725DOI Listing
March 2019
4 Reads

Hepatocellular Carcinoma Risk Stratification by Genetic Profiling in Patients with Cirrhosis.

Semin Liver Dis 2019 Mar 25. Epub 2019 Mar 25.

Liver Tumor Translational Research Program, Simmons Comprehensive Cancer Center, Division of Digestive and Liver Diseases, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas.

Prediction of future hepatocellular carcinoma (HCC) risk in the sizable chronic liver disease population is an urgent unmet need to enable regular HCC screening for early detection. Germline deoxyribonucleic acid polymorphisms likely represent etiology-specific host factors that determine HCC susceptibility, including single nucleotide polymorphisms in , , , and in hepatitis C with or without active viral infection, and , , and in metabolic liver diseases. Transcriptome-based prognostic liver signature in diseased liver tissue has been associated with long-term HCC risk in viral and metabolic etiologies. Read More

View Article

Download full-text PDF

Source
http://www.thieme-connect.de/DOI/DOI?10.1055/s-0039-1681031
Publisher Site
http://dx.doi.org/10.1055/s-0039-1681031DOI Listing
March 2019
15 Reads

Alpha-fetoprotein for Diagnosis, Prognosis, and Transplant Selection.

Semin Liver Dis 2019 Mar 8. Epub 2019 Mar 8.

Department of Medical and Surgical Sciences, Semeiotica Medica, Alma Mater Studiorum - University of Bologna, Bologna, Italy.

Reliable biomarkers are of great clinical value in predicting cancer occurrence/recurrence, anticipating its detection at an asymptomatic stage, supporting the radiological diagnosis, stratifying patients for prognosis and proper therapy, and measuring the response to treatment. Despite the plethora of biomarkers proposed for hepatocellular carcinoma (HCC), the first one identified, α-fetoprotein (AFP), remains the most utilized. This article reviews the lights and shadows of AFP as a surveillance test for patients at risk of HCC, and as a diagnostic test for those with chronic liver disease and a suspected hepatic mass. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1055/s-0039-1677768DOI Listing

Mechanisms and Treatments of Pruritus in Primary Biliary Cholangitis.

Semin Liver Dis 2019 Mar 8. Epub 2019 Mar 8.

Liver Care Network and Organ Care Research, Swedish Medical Center, Seattle, Washington.

Pruritus is a frustrating and sometimes debilitating symptom that commonly accompanies primary biliary cholangitis (PBC). The mechanism by which this symptom manifests remains elusive but extensive research has now shown that the itch is not just "weak pain" as had been the commonly held belief for decades. As this research now shines a light on the many diverse paths by which pruritus might be experienced, the necessity for a comprehensive approach to the symptom becomes clear. Read More

View Article

Download full-text PDF

Source
http://www.thieme-connect.de/DOI/DOI?10.1055/s-0039-1679918
Publisher Site
http://dx.doi.org/10.1055/s-0039-1679918DOI Listing
March 2019
3 Reads

Acetaminophen Hepatotoxicity.

Semin Liver Dis 2019 Mar 8. Epub 2019 Mar 8.

Department of Pharmacology, Toxicology and Therapeutics, University of Kansas Medical Center, Kansas City, Kansas.

Acetaminophen (APAP) is one of the most popular and safe pain medications worldwide. However, due to its wide availability, it is frequently implicated in intentional or unintentional overdoses where it can cause severe liver injury and even acute liver failure (ALF). In fact, APAP toxicity is responsible for 46% of all ALF cases in the United States. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1055/s-0039-1679919DOI Listing
March 2019
1 Read

Concept of Viral Inhibitors via NTCP.

Semin Liver Dis 2019 Feb 17;39(1):78-85. Epub 2019 Jan 17.

Department of Virology II, National Institute of Infectious Diseases, Tokyo, Japan.

Identification of sodium taurocholate cotransporting polypeptide (NTCP) as an entry receptor for hepatitis B and D viruses (HBV and HDV) has not only promoted our understanding of the mechanism underlying the viral entry process, but also provided cell culture models supporting viral infection. These models have greatly facilitated cell-based chemical screening for the discovery of entry inhibitors, and mode of action studies using such inhibitors have shown the advantages of NTCP as a drug target. Furthermore, in vitro chemical screening by application of high-throughput affinity-based technologies that target NTCP has identified a variety of unique small molecules that interfere with viral entry. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1055/s-0038-1676804DOI Listing
February 2019
2 Reads

Inflammation and Liver Cancer: Molecular Mechanisms and Therapeutic Targets.

Semin Liver Dis 2019 02 17;39(1):26-42. Epub 2019 Jan 17.

Division of Digestive and Liver Diseases, Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, California.

Hepatocellular carcinoma (HCC) is associated with chronic inflammation and fibrosis arising from different etiologies, including hepatitis B and C and alcoholic and nonalcoholic fatty liver diseases. The inflammatory cytokines tumor necrosis factor-α and interleukin-6 and their downstream targets nuclear factor kappa B (NF-κB), c-Jun N-terminal kinase (JNK), and signal transducer and activator of transcription 3 drive inflammation-associated HCC. Further, while adaptive immunity promotes immune surveillance to eradicate early HCC, adaptive immune cells, such as CD8 T cells, Th17 cells, and B cells, can also stimulate HCC development. Read More

View Article

Download full-text PDF

Source
http://www.thieme-connect.de/DOI/DOI?10.1055/s-0038-1676806
Publisher Site
http://dx.doi.org/10.1055/s-0038-1676806DOI Listing
February 2019
7 Reads

NASH in Lean Individuals.

Semin Liver Dis 2019 02 17;39(1):86-95. Epub 2019 Jan 17.

Department of Medical Sciences, Division of Gastroenterology, University of Torino, AOU Città della Salute e della Scienza, Torino, Italy.

Nonalcoholic fatty liver disease (NAFLD) is generally associated with obesity and the related comorbidities but it can also develop in subjects with a body mass index (BMI) within the ethnic-specific cutoff of 25 kg/m BMI in Caucasian and 23 kg/m in Asian subjects, the so-called "lean" NAFLD. This sub-phenotype of NAFLD patients has been described across populations of different ethnicity, particularly in Asia, but it can be diagnosed in 10 to 20% of nonobese Americans and Caucasians. Pathophysiological mechanisms underpinning the "lean" phenotype are not completely understood, but they may include a more dysfunctional fat (visceral obesity, differences in adipocyte differentiation and altered lipid turnover), altered body composition (decreased muscle mass), a genetic background, not limited to patatin-like phospholipase domain-containing protein 3 (PNPLA3) C > G polymorphisms, epigenetic changes occurring early in life and a different pattern of gut microbiota. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1055/s-0038-1677517DOI Listing
February 2019
3 Reads

Extracellular Vesicles in Liver Diseases: Diagnostic, Prognostic, and Therapeutic Application.

Semin Liver Dis 2019 Feb 17;39(1):70-77. Epub 2019 Jan 17.

Department of General, Visceral and Thoracic Surgery, German Armed Forces Central Hospital, Koblenz, Germany.

Extracellular vesicles, comprising exosomes, microvesicles, and apoptotic bodies, represent an emerging field in disease diagnostics and prognosis. They can be isolated from peripheral blood of patients as well as from other body fluids and can therefore be considered a minimally invasive liquid biopsy screening tool. Especially their surface antigen composition can reveal information about disease backgrounds. Read More

View Article

Download full-text PDF

Source
http://www.thieme-connect.de/DOI/DOI?10.1055/s-0038-1676122
Publisher Site
http://dx.doi.org/10.1055/s-0038-1676122DOI Listing
February 2019
13 Reads

Child-Pugh Classification: Time to Abandon?

Semin Liver Dis 2019 Feb 11;39(1):96-103. Epub 2019 Jan 11.

Division of Gastroenterology (Liver Unit), University of Alberta, Edmonton, Canada.

The Child-Pugh classification is one of the commonest and oldest bedside tools utilized in estimating prognosis in patients with cirrhosis. However, its usage as a risk prediction tool or indeed a decision-making tool should be revisited. In this review, we discuss some inherent issues with the Child-Pugh classification and present a few contexts in which the current usage of Child-Pugh warrants reassessment, elaborating on its utility in acute variceal bleeding, specifically its role in decision-making on early transjugular intrahepatic portosystemic shunt, as well as its use in the context of hepatocellular carcinoma and drug development and dose adjustment. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1055/s-0038-1676805DOI Listing
February 2019
4 Reads

TGF-β as Multifaceted Orchestrator in HCC Progression: Signaling, EMT, Immune Microenvironment, and Novel Therapeutic Perspectives.

Semin Liver Dis 2019 Feb 26;39(1):53-69. Epub 2018 Dec 26.

National Institute of Gastroenterology "S. de Bellis," Research Hospital, Castellana Grotte, Italy.

Therapeutic attempts to treat hepatocellular carcinoma (HCC) frequently result in a poor response or treatment failure. The efficacy of approved drugs and survival expectancies is affected by an ample degree of variability that can be explained at least in part by the enormous between-patient cellular and molecular heterogeneity of this neoplasm. Transforming growth factor-β (TGF-β) is hyperactivated in a large fraction of HCCs, where it influences complex interactive networks covering multiple cell types and a plethora of other local soluble ligands, ultimately establishing several malignancy traits. Read More

View Article

Download full-text PDF

Source
http://www.thieme-connect.de/DOI/DOI?10.1055/s-0038-1676121
Publisher Site
http://dx.doi.org/10.1055/s-0038-1676121DOI Listing
February 2019
11 Reads

Radiation Therapy in HCC: What Data Exist and What Data Do We Need to Incorporate into Guidelines?

Semin Liver Dis 2019 Feb 7;39(1):43-52. Epub 2018 Dec 7.

Department of Radiation Oncology, University of California San Francisco, San Francisco, California.

Hepatocellular carcinoma (HCC) is a complex and diverse disease, with choice of treatment dependent on a patient's disease burden, location of disease, underlying liver function, and performance status. While radiation therapy (RT) was historically omitted from treatment algorithms, immense technological advances over the past several decades have enabled introduction of RT as an effective and safe treatment option for patients with HCC. Growing prospective and retrospective evidence supports the use of RT, particularly stereotactic body radiotherapy (SBRT), for a wide range of indications in HCC from locally advanced unresectable disease to bridge therapy for liver transplant candidates. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1055/s-0038-1676098DOI Listing
February 2019
3 Reads

Noncoding RNA in Cholangiocarcinoma.

Semin Liver Dis 2019 02 7;39(1):13-25. Epub 2018 Dec 7.

Division of Cancer Therapeutics, The Institute of Cancer Research, London, United Kingdom.

Cholangiocarcinomas (CCAs) are tumors with a dismal prognosis. Early diagnosis is a key challenge because of the lack of specific symptoms, and the curability rate is low due to the difficulty in achieving a radical resection and the intrinsic chemoresistance of CCA cells. Noncoding RNAs (ncRNAs) are transcripts that are not translated into proteins but exert their functional role by regulating the transcription and translation of other genes. Read More

View Article

Download full-text PDF

Source
http://www.thieme-connect.de/DOI/DOI?10.1055/s-0038-1676097
Publisher Site
http://dx.doi.org/10.1055/s-0038-1676097DOI Listing
February 2019
5 Reads

Malignant Vascular Tumors of the Liver in Adults.

Semin Liver Dis 2019 Feb 7;39(1):1-12. Epub 2018 Dec 7.

Department of Radiology, BCLC Group, Hospital Clinic Barcelona, University of Barcelona, Barcelona, Catalonia-Spain.

Hepatic angiosarcoma and epithelioid hemangioendothelioma (EHE) might be clinically considered a spectrum since, although more frequently presenting indolent behavior, EHE occasionally evolves to high-grade neoplasms. However, in most circumstances, pathological and immunohistochemical patterns define this differential diagnosis. More recently, molecular pathways for angiosarcoma and for EHE from other organs and from soft tissue have been proved different, paving the way for future morpho-molecular assessment of their hepatic counterpart. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1055/s-0038-1676120DOI Listing
February 2019
5 Reads

Primary Sclerosing Cholangitis and Psychological Wellbeing: A Scoping Review.

Semin Liver Dis 2019 Feb 22;39(1):104-110. Epub 2018 Nov 22.

Research and Development Unit, Tavistock Centre, Tavistock and Portman NHS Foundation Trust, London, United Kingdom.

Primary sclerosing cholangitis (PSC) is a chronic liver disease resulting from the inflammation and scarring of an individual's hepatic bile ducts. With no curative treatment available and a risk of potentially severe complications and death, it is likely that those diagnosed with the illness may experience impairments in their psychological wellbeing. The aim of this scoping review is to locate, chart, and summarize all available literature on how PSC affects mental health and psychological wellbeing, as well as the factors that may or may not impact on the psychological wellbeing of those who have this diagnosis. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1055/s-0038-1676099DOI Listing
February 2019
19 Reads

Immunomodulatory Effects of Current Targeted Therapies on Hepatocellular Carcinoma: Implication for the Future of Immunotherapy.

Semin Liver Dis 2018 Nov 24;38(4):379-388. Epub 2018 Oct 24.

Graduate Institute of Oncology, National Taiwan University College of Medicine, Taipei, Taiwan.

Multikinase inhibitors with antiangiogenic properties used to be standard therapy for patients with advanced hepatocellular carcinoma (HCC). Recently, several antiangiogenic agents (lenvatinib, cabozantinib, and ramucirumab) have demonstrated antitumor activity for advanced HCC in randomized controlled trials. However, the landscape of drug development for HCC may change dramatically with the advent of immune checkpoint inhibitor therapy, particularly the anti-programmed cell death-1 (anti-PD1) agents. Read More

View Article

Download full-text PDF

Source
http://www.thieme-connect.de/DOI/DOI?10.1055/s-0038-1673621
Publisher Site
http://dx.doi.org/10.1055/s-0038-1673621DOI Listing
November 2018
12 Reads

Liver Toxicity with Cancer Checkpoint Inhibitor Therapy.

Semin Liver Dis 2018 Nov 24;38(4):366-378. Epub 2018 Oct 24.

Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan.

Immune checkpoint inhibition targeted against cytotoxic T-lymphocyte-associated antigen 4 (CTLA-4) and programmed cell death protein 1 (PD-1) has shown clinically significant survival benefit when used to treat multiple types of advanced cancer. These drugs have gained approval by the US Food and Drug Administration and their indications continue to increase. Checkpoint inhibitor therapy is associated with a unique side-effect profile characterized as immune-related adverse events (irAEs), which can result in significant morbidity and rarely mortality. Read More

View Article

Download full-text PDF

Source
http://www.thieme-connect.de/DOI/DOI?10.1055/s-0038-1667358
Publisher Site
http://dx.doi.org/10.1055/s-0038-1667358DOI Listing
November 2018
12 Reads

Liver Injury Associated with Sporting Activities.

Semin Liver Dis 2018 Nov 24;38(4):357-365. Epub 2018 Oct 24.

Division of Gastroenterology and Hepatology, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan.

Exertional heat stroke most commonly develops following prolonged levels of aerobic activity in a warm or humid environment. Hypoperfusion of the vital organs along with activation of the inflammasome can lead to progressive and potentially fatal multiorgan failure including acute liver failure. In the United States, herbal and dietary supplements that are marketed to improve performance, strength, and weight loss are increasingly being used by both amateur and professional athletes. Read More

View Article

Download full-text PDF

Source
http://www.thieme-connect.de/DOI/DOI?10.1055/s-0038-1670656
Publisher Site
http://dx.doi.org/10.1055/s-0038-1670656DOI Listing
November 2018
22 Reads

Liver Transplantation for Neuroendocrine Tumors: What Have We Learned?

Semin Liver Dis 2018 Nov 24;38(4):351-356. Epub 2018 Oct 24.

Department of Hepatobiliary and Pancreatic Surgery and Liver Transplantation, Henri Mondor Hospital, Créteil, France.

Neuroendocrine tumors are slow-growing tumors and associated with prolonged overall survival even in the presence of untreated liver metastases. The presence of liver metastases may be responsible for severe symptoms with impairment of quality of life. Liver resection has been proposed to achieve better symptom control and/or improve overall survival, but this concerns less than 20% of patients with liver metastases. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1055/s-0038-1669936DOI Listing
November 2018
4 Reads

Regulation of Hepatic Inflammation via Macrophage Cell Death.

Semin Liver Dis 2018 Nov 24;38(4):340-350. Epub 2018 Oct 24.

Division of Gastroenterology and Hepatology, Liver Center and Department of Internal Medicine, University of Kansas Medical Center, Kansas City, Kansas.

Macrophages are innate immune cells with diverse functions including clearing infectious agents, inducing inflammation and fibrosis, resolving fibrosis, and restoring tissue integrity. Liver macrophages consist of both resident Kupffer cells and infiltrating macrophages. They have heterogeneous highly plastic phenotypes, and they change their phenotypes rapidly in response to a diverse array of signals present in the injured or recovering liver. Read More

View Article

Download full-text PDF

Source
http://www.thieme-connect.de/DOI/DOI?10.1055/s-0038-1670674
Publisher Site
http://dx.doi.org/10.1055/s-0038-1670674DOI Listing
November 2018
23 Reads

Role of TGR5 (GPBAR1) in Liver Disease.

Semin Liver Dis 2018 Nov 24;38(4):333-339. Epub 2018 Oct 24.

Clinic for Gastroenterology, Hepatology and Infectious Diseases, University Hospital Düsseldorf, Medical Faculty at Heinrich-Heine-University, Düsseldorf, Germany.

TGR5 (GPBAR1) is a G protein-coupled receptor activated by primary and secondary bile acids, which is expressed in different nonparenchymal cells of the liver, such as sinusoidal endothelial cells, Kupffer cells, cholangiocytes as well as activated hepatic stellate cells. In liver, TGR5 modulates microcirculation, inflammation, regeneration, biliary secretion and proliferation as well as gallbladder filling. Absence of TGR5 renders mice more susceptible toward infectious, inflammatory, metabolic as well as cholestatic liver injuries. Read More

View Article

Download full-text PDF

Source
http://www.thieme-connect.de/DOI/DOI?10.1055/s-0038-1669940
Publisher Site
http://dx.doi.org/10.1055/s-0038-1669940DOI Listing
November 2018
19 Reads

Unfolded Protein Response Sensors in Hepatic Lipid Metabolism and Nonalcoholic Fatty Liver Disease.

Authors:
Anne S Henkel

Semin Liver Dis 2018 Nov 24;38(4):320-332. Epub 2018 Oct 24.

Division of Gastroenterology and Hepatology, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois.

Activation of the hepatic unfolded protein response (UPR), a highly conserved cellular response to endoplasmic reticulum (ER) stress, is a firmly established feature of nonalcoholic fatty liver disease (NAFLD). ER stress is now widely accepted as both a cause and a consequence of hepatic steatosis. Moreover, the accumulation of hepatic lipids induces ER stress, which, in turn, disrupts hepatic lipid metabolism thus creating a vicious cycle that potentiates hepatic lipid accumulation. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1055/s-0038-1670677DOI Listing
November 2018
3 Reads

Homeostatic Role of Autophagy in Hepatocytes.

Semin Liver Dis 2018 Nov 24;38(4):308-319. Epub 2018 Oct 24.

Department of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis, Indiana.

Autophagy actively participates in the physiological process of the liver. While the direct effect of autophagy may be limited to the sequestration and degradation of a selective cargo, its overall impact can be broad, affecting many more physiological processes regulated by the particular cargo. This review will discuss two aspects of the importance of autophagy in the liver: metabolic regulation in response to feeding and starvation, and pathological consequences in the absence of autophagy. Read More

View Article

Download full-text PDF

Source
http://www.thieme-connect.de/DOI/DOI?10.1055/s-0038-1669939
Publisher Site
http://dx.doi.org/10.1055/s-0038-1669939DOI Listing
November 2018
9 Reads

ABCB4 Gene Aberrations in Human Liver Disease: An Evolving Spectrum.

Semin Liver Dis 2018 Nov 24;38(4):299-307. Epub 2018 Oct 24.

Department of Medicine II, Saarland University Medical Center, Saarland University, Homburg, Germany.

ATP-binding cassette subfamily B member 4 (ABCB4) is a phospholipid translocator at the canalicular membrane of the hepatocyte, which "flops" phosphatidylcholine into bile. Dysfunction of this transporter due to gene variants can cause liver diseases and has been called ABCB4 deficiency. Several diseases including progressive familial intrahepatic cholestasis type 3 (PFIC3), low phospholipid-associated cholelithiasis (LPAC), a subgroup of patients developing intrahepatic cholestasis of pregnancy (ICP), drug-induced liver injury and chronic cholangiopathy with biliary fibrosis and cirrhosis were attributed to ABCB4 deficiency and characterized in the past decade. Read More

View Article

Download full-text PDF

Source
http://www.thieme-connect.de/DOI/DOI?10.1055/s-0038-1667299
Publisher Site
http://dx.doi.org/10.1055/s-0038-1667299DOI Listing
November 2018
18 Reads

Erratum: Hepatic Dendritic Cells, the Tolerogenic Liver Environment, and Liver Disease.

Semin Liver Dis 2018 08 24;38(3):298. Epub 2018 Jul 24.

Department of Surgery, Tongji Hospital, Huazhong University of Science and Technology, Wuhan, China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1055/s-0038-1667175DOI Listing
August 2018
32 Reads

A Comprehensive Review of Hepatic Sarcoid.

Semin Liver Dis 2018 08 24;38(3):284-297. Epub 2018 Jul 24.

Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.

Sarcoidosis is a multisystem inflammatory disease, which is characterized by the development of noncaseating granulomas amid healthy tissue. While most commonly affecting the mediastinum and/or lungs, sarcoid can also affect the liver, resulting in "hepatic sarcoid." The spectrum of disease in hepatic sarcoid is variable, ranging from asymptomatic or mild liver enzyme abnormalities to end-stage liver disease requiring liver transplantation. Read More

View Article

Download full-text PDF

Source
http://www.thieme-connect.de/DOI/DOI?10.1055/s-0038-1666853
Publisher Site
http://dx.doi.org/10.1055/s-0038-1666853DOI Listing
August 2018
9 Reads

Pyogenic Liver Abscess of Biliary Origin: The Existing Problems and Their Strategies.

Semin Liver Dis 2018 08 24;38(3):270-283. Epub 2018 Jul 24.

Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery, Zhejiang University, First Affiliated Hospital, School of Medicine, Hangzhou, China.

Pyogenic liver abscess (PLA) of biliary origin in Southeast Asia mainly occurs in patients with intrahepatic bile duct stone (IBDS) and extrahepatic bile duct stone (EBDS), bilioenteric anastomosis, or biliary stent. IBDS, as an endemic to Southeast Asia, remains a frequent etiology of acute cholangitis and PLA. PLA related to IBDS is characterized by high incidences of PLA recurrence and death related to infection, and difficulties in diagnosis of concomitant cholangicarcinoma. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1055/s-0038-1661363DOI Listing
August 2018
5 Reads

Organ Preservation in Liver Transplantation.

Semin Liver Dis 2018 08 24;38(3):260-269. Epub 2018 Jul 24.

Multivisceral Transplant Unit, Department of Surgery, Oncology and Gastroenterology, Padova University Hospital, Padova, Italy.

The discrepancy between the number of patients awaiting liver transplantation and the number of available donors has become a key issue in the transplant setting. Various strategies to cope with the donor shortage problem and to increase the use of suboptimal grafts have been explored. Machine perfusion has been applied ex situ to liver grafts in the effort to improve static cold-storage preservation. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1055/s-0038-1666840DOI Listing
August 2018
5 Reads

The Emerging Importance of Liver Sinusoidal Endothelial Cells in Regulating Injury during Machine Perfusion of Deceased Liver Donors.

Semin Liver Dis 2018 08 24;38(3):252-259. Epub 2018 Jul 24.

Centre for Liver Research, Institute for Biomedical Research, University of Birmingham College of Medical and Dental Sciences, The Medical School, Birmingham, United Kingdom.

While majority of liver transplants worldwide continue to be performed using deceased donor organs, the demands for donor livers continues to exceed the current supply. In an attempt to maximize the number of potentially usable donor livers and expand the current donor pool, there is intense global research by various groups exploring the role of machine perfusion in the liver transplantation, particularly with respect to the machine perfusion of extended-criteria liver donors. In this review, the authors summarize the current field of machine perfusion strategies as applied to deceased donor liver transplantation and how therapeutic targeting of the liver sinusoidal endothelial cell may improve the quality of donor livers. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1055/s-0038-1661371DOI Listing
August 2018
4 Reads

Hepatocellular Carcinoma with Portal Vein Tumor Involvement: Best Management Strategies.

Semin Liver Dis 2018 08 24;38(3):242-251. Epub 2018 Jul 24.

Department of Medicine, Harvard Medical School, Newton, Massachusetts.

Portal vein tumor thrombosis (PVTT) commonly occurs in patients with hepatocellular carcinoma (HCC). Patients with PVTT usually have an aggressive disease course, decreased liver function reserve, limited treatment options, higher recurrence rates after treatment, and, therefore, worse overall survival. Among untreated HCC patients with PVTT, the median overall survival has been reported as low as 2 to 4 months. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1055/s-0038-1666805DOI Listing
August 2018
4 Reads

Renal Function in Cirrhosis: A Critical Review of Available Tools.

Semin Liver Dis 2018 08 24;38(3):230-241. Epub 2018 Jul 24.

Unit of Internal Medicine and Hepatology (UIMH), Department of Medicine - DIMED, University of Padova, Italy.

Patients with cirrhosis have a high prevalence of renal dysfunction. The susceptibility to renal dysfunction is due to both the severe splanchnic arterial vasodilation and the systemic inflammation observed in these patients. An accurate assessment of renal function is recommended in all patients with cirrhosis. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1055/s-0038-1661372DOI Listing
August 2018
6 Reads

Prevention and Management of Bleeding Risk Related to Invasive Procedures in Cirrhosis.

Semin Liver Dis 2018 08 24;38(3):215-229. Epub 2018 Jul 24.

Gastroenterology Unit, Department of Medical Specialties, Università degli Studi di Modena and Reggio Emilia, and Azienda Ospedaliero-Universitaria di Modena, Modena, Italy.

Cirrhosis represents the end stage of chronic liver disease and its transition from a compensated to a decompensated status is mainly driven by portal hypertension and systemic inflammation. Although relevant modifications in the evaluation of the coagulative balance in cirrhosis across its natural history have occurred and alterations in routine indices of hemostasis have lost their role as indicators of the hemorrhagic risk of patients with liver cirrhosis, these are still perceived as prone to bleed when admitted to invasive procedures. This view, which is still present in guidelines addressing the management of bleeding risk, makes preprocedural transfusion of plasma and platelets still an ongoing clinical practice. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1055/s-0038-1660523DOI Listing
August 2018
3 Reads
4.950 Impact Factor

Potential Mechanisms Underlying the Role of Coffee in Liver Health.

Semin Liver Dis 2018 08 24;38(3):193-214. Epub 2018 Jul 24.

Department of Gastroenterology and Hepatology, Erasmus MC University Medical Centre, Rotterdam, The Netherlands.

Coffee, the most consumed hot beverage worldwide, is composed of many substances, of which polyphenols, caffeine, and diterpenoids are well studied. Evidence on potential effects of coffee on human health has been accumulating over the past decades. Specifically, coffee has been postulated to be hepatoprotective in several epidemiological and clinical studies. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1055/s-0038-1666869DOI Listing
August 2018
4 Reads

The Micro-Elimination Approach to Eliminating Hepatitis C: Strategic and Operational Considerations.

Semin Liver Dis 2018 08 9;38(3):181-192. Epub 2018 Jul 9.

Department of Medicine, Clinical and Research Center, Humanitas Hospital, Rozzano, Italy.

The introduction of efficacious new hepatitis C virus (HCV) treatments galvanized the World Health Organization to define ambitious targets for eliminating HCV as a public health threat by 2030. Formidable obstacles to reaching this goal can best be overcome through a micro-elimination approach, which entails pursuing elimination goals in discrete populations through multi-stakeholder initiatives that tailor interventions to the needs of these populations. Micro-elimination is less daunting, less complex, and less costly than full-scale, country-level initiatives to eliminate HCV, and it can build momentum by producing small victories that inspire more ambitious efforts. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1055/s-0038-1666841DOI Listing
August 2018
28 Reads

Hepatic Dendritic Cells, the Tolerogenic Liver Environment, and Liver Disease.

Semin Liver Dis 2018 05 5;38(2):170-180. Epub 2018 Jun 5.

Department of Surgery, Tongji Hospital, Huazhong University of Science and Technology, Wuhan, China.

The unique liver immune microenvironment favors resistance to inflammation that promotes normal physiological function. At the same time, it endows the liver with tolerogenic properties that may promote pathological processes. Hepatic dendritic cells (HDCs) initiate and orchestrate immune responses depending on signals they receive from the local environment and are thought to contribute to liver tolerance. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1055/s-0038-1646949DOI Listing
May 2018
25 Reads

Emerging Technologies for the Diagnosis of Perihilar Cholangiocarcinoma.

Semin Liver Dis 2018 05 5;38(2):160-169. Epub 2018 Jun 5.

Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota.

The diagnosis of malignant biliary strictures remains problematic, especially in the perihilar region and in primary sclerosing cholangitis (PSC). Conventional cytology obtained during endoscopic retrograde cholangiography (ERC)-guided brushings of biliary strictures is suboptimal due to limited sensitivity, albeit it remains the gold standard with a high specificity. Emerging technologies are being developed and validated to address this pressing unmet patient need. Read More

View Article

Download full-text PDF

Source
http://www.thieme-connect.de/DOI/DOI?10.1055/s-0038-1655775
Publisher Site
http://dx.doi.org/10.1055/s-0038-1655775DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6463495PMC
May 2018
11 Reads

Endoscopic Ultrasound for the Hepatologist: A Comprehensive Review.

Semin Liver Dis 2018 05 5;38(2):145-159. Epub 2018 Jun 5.

Digestive Endoscopy Unit, Catholic University, Rome, Italy.

In the last few years, the diagnostic and therapeutic utilization of endoscopic ultrasound (EUS) for a variety of liver conditions has exponentially grown. We performed a thorough search for all available studies on the performance of diagnostic and therapeutic EUS in the field of hepatology. This article reviews the indication of EUS in the evaluation and treatment of portal hypertension, portal vein pressure measurement, focal liver lesions, and parenchymal liver diseases, and presents all the clinical evidences available so far in this regard. Read More

View Article

Download full-text PDF

Source
http://www.thieme-connect.de/DOI/DOI?10.1055/s-0038-1656511
Publisher Site
http://dx.doi.org/10.1055/s-0038-1656511DOI Listing
May 2018
13 Reads

Bacterial Infections in Acute-on-Chronic Liver Failure.

Semin Liver Dis 2018 05 5;38(2):121-133. Epub 2018 Jun 5.

State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.

Acute-on-chronic liver failure (ACLF) is a newly recognized clinical syndrome characterized by preexisting chronic liver disease or cirrhosis with organ failure and high 28-day mortality (50-90%). Bacterial infections (BIs) play pivotal roles in the development and progression of ACLF either as a main precipitating event or a specific complication. The main organisms isolated as triggering ACLF are Gram-positive bacteria, followed by Gram-negative bacteria. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1055/s-0038-1657751DOI Listing
May 2018
6 Reads

Management of HCV-Related Liver Disease in Hemophilia and Thalassemia.

Semin Liver Dis 2018 05 5;38(2):112-120. Epub 2018 Jun 5.

Department of Medicine, Clinical and Research Center, Humanitas Hospital, Rozzano, Italy.

Chronic infection with the hepatitis C virus (HCV) has long been the dominant complication of substitution therapy in patients with inherited blood disorders and the cause of anticipated death due to end-stage liver disease. In hemophilia, transmission of HCV with clotting factors concentrates started to be curbed in the mid-1980s following the adoption of procedures of virus inactivation of concentrates based on heat, whereas in the 1990s treatment of HCV infection with interferon monotherapy was attempted, however, with little success. The advent of combination therapy of interferon with ribavirin led to a substantial improvement of treatment outcome (40% rate of cure), that however was still of limited efficacy in patients with advanced liver disease, those with high load of HCV genotype 1, and patients coinfected with the human immunodeficiency virus. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1055/s-0038-1655774DOI Listing
May 2018
8 Reads

A Primer on Systematic Reviews and Meta-Analyses.

Semin Liver Dis 2018 05 5;38(2):103-111. Epub 2018 Jun 5.

Division of Gastroenterology, University of California San Diego, La Jolla, California.

With the rapid growth of biomedical literature, there is increasing need to make meaningful inferences from a comprehensive and complex body of evidence. Systematic reviews with or without meta-analyses offer an objective and summative approach to synthesize knowledge and critically appraise evidence to inform clinical practice. Systematic reviews also help identify key knowledge gaps for future investigation. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1055/s-0038-1655776DOI Listing
May 2018
3 Reads

Noninferiority Clinical Trials: The Good, the Bad, and the Ugly.

Semin Liver Dis 2018 05 5;38(2):97-102. Epub 2018 Jun 5.

L-Biostat School of Public Health, KU Leuven, University of Leuven, Leuven, Belgium.

For decades, the superiority trial has been the most popular design to assess the efficacy of newly developed drugs in a randomized controlled clinical trial. In a superiority trial, the aim is to show that the new (experimental) treatment is better than the standard treatment or placebo. However, it becomes increasingly difficult to improve the efficacy upon that of existing drugs. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1055/s-0038-1655777DOI Listing
May 2018
3 Reads

Surgical Complications after Right Hepatectomy for Live Liver Donation: Largest Single-Center Western World Experience.

Semin Liver Dis 2018 05 22;38(2):134-144. Epub 2018 Mar 22.

Multi-Organ Transplant Unit, Division of General Surgery, Department of Surgery, University Health Network, University of Toronto, Toronto, Ontario, Canada.

The authors assessed the incidence, management, and risk factors for postoperative complications after right lobe (RL) live donor hepatectomy in a high-volume center in North America. All donors undergoing an RL live donor hepatectomy between 2000 and 2017 at our institution were included. The primary outcome was the development of complications (both medical and surgical). Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1055/s-0038-1636932DOI Listing
May 2018
9 Reads